Lung cancer

FILE - In this Aug. 19, 2016, file photo U.S. Supreme Court Justice, Ruth Bader Ginsburg, is introduced during the keynote address for the State Bar of New Mexico's Annual Meeting in Pojoaque. The Supreme Court announced Aug. 23, 2019, that Ginsburg has been treated for a malignant tumor. (AP Photo/Craig Fritz, File)
The Associated Press
August 24, 2019 - 2:35 am
WASHINGTON (AP) — Justice Ruth Bader Ginsburg has completed radiation therapy for a cancerous tumor on her pancreas and there is no evidence of the disease remaining, the Supreme Court said Friday. It is the fourth time that the 86-year-old justice has announced that she has been treated for cancer...
Read More
FILE - In this Oct. 29, 2018 file photo, Uruguay's President Tabare Vazquez attends a military ceremony in Montevideo, Uruguay. Vazquez announced at a press conference on Tuesday, Aug. 20, 2019 that he has been diagnosed with lung cancer. (AP Photo/Matilde Campodonico, File)
August 20, 2019 - 8:19 pm
MONTEVIDEO, Uruguay (AP) — Uruguayan President Tabaré Vázquez has announced that he has cancer and will have a more complete diagnosis in coming days. Vázquez said Tuesday: "In a tomographic study, a right pulmonary nodule was found, with very clear characteristics that it could be malignant." The...
Read More
This undated photo provided by Roszell Mack, Jr. in May 2019 shows him at his office in Lexington, Ky. At the age of 87, he is able to work nearly fulltime at the horse farm nine years after being diagnosed with lung cancer that had spread to his bones and lymph nodes. "I go in every day, I'm the first one there," said Mack, who helped test Merck's Keytruda, a therapy that helps the immune system see and fight cancer. "I'm feeling well and I have a good quality of life." The biggest drawback of these drugs: They often cost $100,000 or more a year, although what patients pay out of pocket varies by insurance, income and other things. (Courtesy Roszell Mack, Jr. via AP)
June 02, 2019 - 11:14 am
CHICAGO (AP) — Newer drugs are improving survival for some people with hard-to-treat forms of cancer. One study in advanced lung cancer tested Keytruda (kee-TROO-dah), a drug that helps the immune system fight tumors. Five-year survival was 23% for people who got Keytruda as part of their initial...
Read More
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports financial results Tuesday, April 30, 2019. (AP Photo/Seth Wenig, File)
April 30, 2019 - 6:50 am
Surging sales of vaccines and the cancer immunotherapy drug Keytruda led to a quadrupling of profit at Merck during the first quarter as it blew past Wall Street expectations. Sales of Keytruda jump 55% to $2.27 billion, about one-quarter of its total revenue. During the quarter, the injected...
Read More
FILE - In this May 25, 2017 file photo, chemotherapy drugs are administered to a patient at a hospital in Chapel Hill, N.C. The U.S. cancer death rate has been falling between 1991 and 2016, and so far there’s little sign the decline is slowing, according to a report released on Tuesday, Jan. 8, 2019. (AP Photo/Gerry Broome)
January 08, 2019 - 12:37 pm
NEW YORK (AP) — The U.S. cancer death rate has hit a milestone: It's been falling for at least 25 years, according to a new report. Lower smoking rates are translating into fewer deaths. Advances in early detection and treatment also are having a positive impact, experts say. But it's not all good...
Read More